Anlon Healthcare Limited IPO

Apply 0
Avoid 0

Closing in

Days
Hours
Mins
Secs

Don't Miss It! Mark Your Calender Now:


Anlon Healthcare is a chemical manufacturing company engaged in producing:

a) High Purity Pharmaceutical Intermediates – raw materials and key starting materials used in the manufacturing of Active Pharmaceutical Ingredients (APIs).

b) Active Pharmaceutical Ingredients (APIs) – core raw materials used in pharmaceutical formulations like tablets, capsules, syrups, ointments, as well as nutraceuticals, personal care, and veterinary products.

The company is among the few manufacturers of Loxoprofen Sodium Dihydrate in India, an important API used in the treatment of various pain and inflammation-related conditions.

Product Portfolio

a) Anlon Healthcare’s diversified portfolio includes Pharma Intermediates, APIs, Nutraceutical APIs, Personal Care Ingredients and Veterinary APIs. Products comply with leading pharmacopeia standards such as IP, BP, EP, JP, and USP.

b) Current Product Development Status: 65 commercialized products, 28 products at pilot stage and 49 products under laboratory testing

Custom Manufacturing & R&D

The company also undertakes custom manufacturing services for complex or novel compounds, ensuring higher-than-standard purity levels.

i) Expertise in reducing impurities and optimizing processes.
ii) Active involvement in Drug Master File (DMF) preparation and filings across global markets.
iii) Regulatory approvals already secured from Brazil (ANVISA), China (NMPA), and Japan (PMDA), with filings in multiple other geographies including the EU, Russia, USA, and Spain.

Global Presence

Anlon Healthcare serves both domestic and international markets. Its products are supplied to over 15 countries, including Italy, Germany, South Korea, China, Argentina, Chile, Colombia, Mexico, Egypt, Turkey, Japan, Brazil, UK, and UAE.

Key Strengths

i) Strong product portfolio with presence in multiple therapeutic and application segments.
ii) One of the few Indian manufacturers of Loxoprofen Sodium Dihydrate.
iii) Experienced promoters and management team driving strategic growth.
iv) High entry barriers due to lengthy customer approval cycles and stringent product quality standards.
v) In-house QC & QA systems ensuring consistent quality and regulatory compliance.

Objects of the Anlon Healthcare Limited IPO:

Company proposes to utilize the Net Proceeds from the Issue towards the following objects: 1. Funding capital expenditure for expansion of Manufacturing Facility (₹30.71 cr) 2. Full or part repayment and/or prepayment of borrowings (₹5 cr) 3. Working capital requirements (₹43.15 cr) 4. General corporate purposes

Anlon Healthcare Limited IPO Details:

Open Date: Aug 26 2025
Close Date: Aug 29 2025
Total Shares: 1,33,00,000
Face Value: ₹ 10 Per Equity Share
Issue Type: Book Building
Issue Size: 121.03 Cr.
Lot Size: 164 Shares
Issue Price: ₹ 86-91 Per Equity Share
Listing At: NSE,BSE

Promoters And Management:

1. Punitkumar R. Rasadia, Chairman and Managing Director, has been associated with the Company since inception. He holds a Master’s degree in Industrial Chemistry and brings over 11 years of experience in the pharmaceutical industry. He is responsible for strategy, operations, and business growth, and is also associated with ventures such as Anlon Chemical Research Organization, Advintel Medicare Private Limited, and Anlon Lifescience Private Limited. 2. Atulkumar Vachhani, is the Whole-time Executive Director and a founding Promoter of the Company. With over 11 years of experience in the pharmaceutical industry, he oversees the Company’s administration, strategy, finance, and sales functions. His responsibilities include strategy formulation, operations management, and product innovation. He is also associated with Anlon Chemical Research Organization, Advintel Medicare Private Limited, and Anlon Lifescience Private Limited. 3. Mamata Punitkumar Rasadia, is a Non-Executive Non-Independent Director and Promoter of the Company, associated since July 15, 2024. She holds a Master of Science degree in Chemistry and a Diploma in Pharmacy, both from Saurashtra University.

Financials of Anlon Healthcare Limited IPO:

To be updated shortly

Comparison With Peers:

To be updated shortly

Lead Manager of Anlon Healthcare Limited IPO:

  1. Interactive Financial Services

Registrar of Anlon Healthcare Limited IPO:

  1. Kfin Technology Private Limited

Discussion on Anlon Healthcare Limited IPO:

Leave a Reply